Industries de la santé
01 Mars 2011
Positive Pre-Clinical Data From Muscle Injury Study Moves Pluristem Toward Second Multi-Billion Dollar Clinical IndicationResearch Conducted at Berlin-Brandenburg Center for Regenerative Therapies and Charite University of Medicine Offers New Potentially Promising Cell Treatment for the Muscle Injury Market |HAIFA , Israel , March 1, 2011 -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI)...